Cargando…

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Detalles Bibliográficos
Autores principales: Spartalis, Michael, Tzatzaki, Eleni, Nikiteas, Nikolaos I., Spartalis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731292/
https://www.ncbi.nlm.nih.gov/pubmed/29145223
http://dx.doi.org/10.14744/AnatolJCardiol.2017.8009
_version_ 1783286496069943296
author Spartalis, Michael
Tzatzaki, Eleni
Nikiteas, Nikolaos I.
Spartalis, Eleftherios
author_facet Spartalis, Michael
Tzatzaki, Eleni
Nikiteas, Nikolaos I.
Spartalis, Eleftherios
author_sort Spartalis, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-5731292
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-57312922017-12-18 Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention Spartalis, Michael Tzatzaki, Eleni Nikiteas, Nikolaos I. Spartalis, Eleftherios Anatol J Cardiol Letter to the Editor Kare Publishing 2017-11 /pmc/articles/PMC5731292/ /pubmed/29145223 http://dx.doi.org/10.14744/AnatolJCardiol.2017.8009 Text en Copyright: © 2017 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Letter to the Editor
Spartalis, Michael
Tzatzaki, Eleni
Nikiteas, Nikolaos I.
Spartalis, Eleftherios
Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title_full Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title_fullStr Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title_full_unstemmed Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title_short Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
title_sort individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731292/
https://www.ncbi.nlm.nih.gov/pubmed/29145223
http://dx.doi.org/10.14744/AnatolJCardiol.2017.8009
work_keys_str_mv AT spartalismichael individualizedintensifiedantiplatelettherapybasedonplateletreactivitytestingreducestheincidenceofcardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention
AT tzatzakieleni individualizedintensifiedantiplatelettherapybasedonplateletreactivitytestingreducestheincidenceofcardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention
AT nikiteasnikolaosi individualizedintensifiedantiplatelettherapybasedonplateletreactivitytestingreducestheincidenceofcardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention
AT spartaliseleftherios individualizedintensifiedantiplatelettherapybasedonplateletreactivitytestingreducestheincidenceofcardiovasculareventsinpatientsundergoingpercutaneouscoronaryintervention